Patient-level digital twins expected to strengthen evidence generation in Phase1/2 clinical study evaluating VTx-002, a first-in-class vectorized antibody targeting TDP-43 pathology in patients with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results